IntelGenx Partner Insud Pharma Submits ANDA for Co-Developed Generic Buccal Film Product
04. Oktober 2018 08:16 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Oct. 04, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today announced that an Abbreviated New Drug Application (“ANDA”)...